CF
INSM icon

Cantor Fitzgerald’s Insmed INSM Stock Holding History

Cantor Fitzgerald’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.8M Buy
+11,000
New +$1.69M 0.03% 158
2025
Q2 		– Sell
-5,060
Closed -$386K – 493
2025
Q1 		$386K Sell
5,060
-4,940
-49% -$378K 0.01% 168
2024
Q4 		$682K Buy
+10,000
New +$720K 0.01% 103

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Cantor Fitzgerald's INSM Position: Q1 2026 in Review

Cantor Fitzgerald opened a new position in Insmed (INSM) in Q1 2026: 11,000 shares worth $1.8M. The stake represents 0.03% of the portfolio and ranks #158 among its holdings. This is a return to the name: Cantor Fitzgerald previously reported a position in INSM as recently as Q1 2025.

Cantor Fitzgerald first reported a position in INSM in Q4 2024 and has held it in 3 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Cantor Fitzgerald held 11,000 shares of Insmed worth $1.8M as of Q1 2026.
  • Insmed was a new Cantor Fitzgerald position in Q1 2026.
  • Insmed made up 0.03% of Cantor Fitzgerald's portfolio in Q1 2026, its #158 holding.
  • Cantor Fitzgerald first reported a position in Insmed in Q4 2024 and has held it in 3 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Cantor Fitzgerald's 13F filing for Q1 2026, filed 15 May 2026.